Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

Researchers developed a wearable jumpsuit with sensors that can objectively measure an infant’s gross motor development and, ...

In patients who have previously undergone corneal refractive surgery, the asymmetric segmental design of the Acunex VarioMax ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

As cornea specialists, we talk a lot about how to get timely referrals of keratoconus patients from optometrists and ...

The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a recognized role ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

One question that freshly matriculated medical students become well-versed in answering is “what specialty are you interested in?”I answered that question hundreds of times with an ever-evolving ...